BioSpace News Archive

Pharm Country

Protara Therapeutics to Participate in the Guggenheim Healthcare Talks 2022 Oncology Conference

Protara Therapeutics, Inc. announced that management will participate in a virtual fireside chat at the Guggenheim Healthcare Talks 2022 Oncology Conference on February 9, 2022 at 4:00 PM ET.

February 1, 2022

·

1 min read

Pharm Country

electroCore, Inc. Announces Completion of Enrollment in the TRANSIT Study of non-Invasive Vagus Nerve Stimulation (nVNS) in Post-Operative Ileus

electroCore, Inc. today announced enrollment has been completed for the TRANSIT study of non-invasive vagal nerve stimulation (nVNS) to reduce ileus after colorectal surgery.

February 1, 2022

·

7 min read

Drug Development

Aldeyra Therapeutics Announces Publication of Phase 2 Clinical Trial of Reproxalap in Allergen Chamber Model

Aldeyra Therapeutics, Inc. today announced that results from the randomized, double-masked, vehicle-controlled, crossover Phase 2 clinical trial of reproxalap in an allergen chamber model have been published in the peer-reviewed journal Clinical Ophthalmology.

February 1, 2022

·

9 min read

Business

Biosero Collaborates with Araceli Biosciences for High-Content Analysis

Biosero, Inc. today announced a collaboration with Araceli Biosciences that will allow scientists to integrate Araceli’s Endeavor™ high-speed imaging platform.

February 1, 2022

·

3 min read

Business

iECURE Expands Leadership Team with the Appointment of Mark Semanick as VP and Head of Technical Operations and Brad Dickerson as VP of Project Management & Patient Advocacy

iECURE today announced that it has expanded its management team by adding two experienced industry executives into key roles within the organization.

February 1, 2022

·

3 min read

Business

Veru Enters into Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company to Evaluate Enobosarm in Combination with Verzenio® in Phase 3 ENABLAR-2 Trial

Veru Inc. today announced that it has entered into a clinical trial collaboration and supply agreement with Eli Lilly and Company.

February 1, 2022

·

15 min read

Biotech Bay

Jaguar Health Announces Completion of Third-party, Investigator-Initiated Study of Crofelemer, which is Expected to Support Orphan Drug Designation (ODD) for Crofelemer for Congenital Diarrheal Disorders (CDD)

Jaguar Health, Inc. (NASDAQ:JAGX) and Napo Pharmaceuticals, the company’s wholly owned subsidiary, today announced the completion of a third-party, investigator-initiated preclinical enterocyte.

February 1, 2022

·

6 min read

Biotech Bay

NHS Study Demonstrates Eko Smart Stethoscope Can Identify Heart Failure

Eko announced that the Imperial College of London, in conjunction with the UK National Health Service, published a study1 which highlights Eko’s ability to screen patients for heart failure in seconds with AI during physical exams.

February 1, 2022

·

4 min read

Biotech Bay

Neuvivo Announces Publication of Paper on ALS Drug Candidate NP001 in Peer-Reviewed Journal, Muscle & Nerve

Neuvivo today announced the publication of a paper on its lead candidate drug NP001 for the treatment of ALS in the peer-reviewed journal Muscle & Nerve.

February 1, 2022

·

5 min read

Business

Shineco, Inc. Appoints Professor Qiyin Sun as Chief Medical Consultant

Shineco, Inc., a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that the Company has appointed Professor Qiyin Sun as the Chief Medical Consultant.

February 1, 2022

·

5 min read